CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 16, 2019--

Oncorus, Inc., an oncolytic virus therapeutics company focused on driving innovation to transform outcomes for cancer patients, today announced that its President and Chief Executive Officer, Ted Ashburn, M.D., Ph.D., will provide a company overview and pipeline update at the following upcoming healthcare investor conferences in New York City:

  • UBS Global Healthcare Conference on Tuesday, May 21, 2019 at 1:30 p.m. ET
  • Jefferies 2019 HealthcareConference on Wednesday, June 5, 2019 at 9:30 a.m. ET

About Oncorus

At Oncorus, we are driving innovation to deliver next-generation, best-in-class oncolytic virus therapies to transform outcomes for cancer patients. We are advancing a portfolio of locally and systemically administered oncolytic virus therapies for a broad spectrum of indications with significant unmet needs based on our oncolytic herpes simplex virus and synthetic oncolytic virus platforms. Our team has engineered proprietary, multidimensional innovations into both platforms to enable us to deliver on the full potential of oncolytic virus therapies to dramatically improve outcomes for cancer patients. Please visit www.oncorus.com to learn more.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190516005307/en/

CONTACT: Media Contact:

Liz Melone

liz@scientpr.com

617-256-6622

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH ONCOLOGY GENERAL HEALTH

SOURCE: Oncorus, Inc.

Copyright Business Wire 2019.

PUB: 05/16/2019 07:00 AM/DISC: 05/16/2019 07:00 AM

http://www.businesswire.com/news/home/20190516005307/en

Copyright Business Wire 2019.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

Thank you for Reading!

Please log in, or sign up for a new account and purchase a subscription to read or post comments.